Events
- October 21 - 24, 2008
Poster Presentation at the EORTC-NCI-AACR 2008 Conference
- October 14, 2008
2008 Q3 Earnings Announcement and Webcast
News
- December 10, 2008
Thallion Announces a Review of Strategic Alternatives
- November 18, 2008
Thallion Initiates Enrollment in Phase II Metastatic Melanoma Trial
- October 24, 2008
Thallion's TLN-4601 Inhibits Mutated K-RAS Signaling in Cancer Cells